Randomized Phase III Trial to Evaluate Radiopharmaceuticals and Zoledronic Acid in the Palliation of Osteoblastic Metastases From Lung, Breast, and Prostate Cancer
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00006665/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
RATIONALE: Zoledronate, vitamin D and calcium may prevent or delay bone pain and other
symptoms caused by bone metastases. It is not yet known whether giving zoledronate together
with vitamin D and calcium is more effective with or without strontium 89 or samarium 153 in
treating patients with bone metastases from prostate cancer, lung cancer, or breast cancer.
PURPOSE: This randomized phase III trial is studying zoledronate, vitamin D, and calcium to
see how well they work compared to zoledronate, vitamin D, calcium, and either strontium 89
or samarium 153 in preventing or delaying bone problems in patients with bone metastases from
prostate cancer, lung cancer, or breast cancer.
提供机构：
Vivli
创建时间：
2021-02-09
